JJ has announced its acquisition of IntraCellular Therapies, a developer of innovative psychiatric drugs, for a staggering $146 billion. This strategic move is expected to enhance JJ’s portfolio in the mental health sector and expand its research capabilities in developing treatments for psychiatric disorders.
Tag: JJ
JJ Acquires IntraCellular Therapies for $146 Billion in Major Pharmaceutical Deal
JJ has announced its acquisition of IntraCellular Therapies, a developer of innovative psychiatric drugs, for a staggering $146 billion. This strategic move is expected to enhance JJ’s portfolio in the mental health sector and expand its research capabilities in developing treatments for psychiatric disorders.